nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—CALM2—VEGFR1 specific signals—VEGFA—age related macular degeneration	0.00393	0.00393	CbGpPWpGaD
Cinchocaine—CALM1—VEGFR1 specific signals—VEGFA—age related macular degeneration	0.00393	0.00393	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—F13B—age related macular degeneration	0.00385	0.00385	CbGpPWpGaD
Cinchocaine—CALM3—Platelet degranulation—CD36—age related macular degeneration	0.00379	0.00379	CbGpPWpGaD
Cinchocaine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—KDR—age related macular degeneration	0.00373	0.00373	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—F13B—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—F13B—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Cinchocaine—CALM2—Platelet degranulation—CD36—age related macular degeneration	0.00366	0.00366	CbGpPWpGaD
Cinchocaine—CALM1—Platelet degranulation—CD36—age related macular degeneration	0.00366	0.00366	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—SERPING1—age related macular degeneration	0.00362	0.00362	CbGpPWpGaD
Cinchocaine—CALM3—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00361	0.00361	CbGpPWpGaD
Cinchocaine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—KDR—age related macular degeneration	0.0036	0.0036	CbGpPWpGaD
Cinchocaine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—KDR—age related macular degeneration	0.0036	0.0036	CbGpPWpGaD
Cinchocaine—CALM3—VEGFR2 mediated cell proliferation—VEGFA—age related macular degeneration	0.00357	0.00357	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00356	0.00356	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—SERPING1—age related macular degeneration	0.0035	0.0035	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—SERPING1—age related macular degeneration	0.0035	0.0035	CbGpPWpGaD
Cinchocaine—CALM2—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00349	0.00349	CbGpPWpGaD
Cinchocaine—CALM1—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00349	0.00349	CbGpPWpGaD
Cinchocaine—SCN10A—Axon guidance—KDR—age related macular degeneration	0.00349	0.00349	CbGpPWpGaD
Cinchocaine—CALM2—VEGFR2 mediated cell proliferation—VEGFA—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Cinchocaine—CALM1—VEGFR2 mediated cell proliferation—VEGFA—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Cinchocaine—CALM3—Alzheimers Disease—APOE—age related macular degeneration	0.00337	0.00337	CbGpPWpGaD
Cinchocaine—CALM2—Alzheimers Disease—APOE—age related macular degeneration	0.00326	0.00326	CbGpPWpGaD
Cinchocaine—CALM1—Alzheimers Disease—APOE—age related macular degeneration	0.00326	0.00326	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—C9—age related macular degeneration	0.00326	0.00326	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—C9—age related macular degeneration	0.00315	0.00315	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—C9—age related macular degeneration	0.00315	0.00315	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—RAD51B—age related macular degeneration	0.00314	0.00314	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—RAD51B—age related macular degeneration	0.00303	0.00303	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—RAD51B—age related macular degeneration	0.00303	0.00303	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—SLC16A8—age related macular degeneration	0.00292	0.00292	CbGpPWpGaD
Cinchocaine—CALM3—Diseases associated with visual transduction—APOE—age related macular degeneration	0.00291	0.00291	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—CD36—age related macular degeneration	0.00288	0.00288	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CFI—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—SLC16A8—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—SLC16A8—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Cinchocaine—CALM2—Diseases associated with visual transduction—APOE—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Cinchocaine—CALM1—Diseases associated with visual transduction—APOE—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CFI—age related macular degeneration	0.00273	0.00273	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CFI—age related macular degeneration	0.00273	0.00273	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CFHR3—age related macular degeneration	0.00263	0.00263	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—NMNAT1—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Cinchocaine—CALM3—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00259	0.00259	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CFHR3—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CFHR3—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Cinchocaine—CALM2—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00251	0.00251	CbGpPWpGaD
Cinchocaine—CALM1—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00251	0.00251	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—KDR—age related macular degeneration	0.00249	0.00249	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—KDR—age related macular degeneration	0.00245	0.00245	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by VEGF—KDR—age related macular degeneration	0.00245	0.00245	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00242	0.00242	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by VEGF—KDR—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by VEGF—KDR—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—C2—age related macular degeneration	0.00234	0.00234	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—ELOVL4—age related macular degeneration	0.00228	0.00228	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—C2—age related macular degeneration	0.00226	0.00226	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—C2—age related macular degeneration	0.00226	0.00226	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00211	0.00211	CbGpPWpGaD
Cinchocaine—CALM1—Endochondral Ossification—VEGFA—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Cinchocaine—CALM2—Endochondral Ossification—VEGFA—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Cinchocaine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—SQSTM1—age related macular degeneration	0.00204	0.00204	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00204	0.00204	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—CD36—age related macular degeneration	0.00202	0.00202	CbGpPWpGaD
Cinchocaine—CALM3—Disease—NMNAT1—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Cinchocaine—CALM3—Disease—RDH8—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Cinchocaine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Cinchocaine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—SQSTM1—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—SQSTM1—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CFH—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Cinchocaine—CALM1—Disease—RDH8—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Cinchocaine—CALM2—Disease—NMNAT1—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Cinchocaine—CALM1—Disease—NMNAT1—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Cinchocaine—CALM2—Disease—RDH8—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Cinchocaine—SCN10A—Axon guidance—VEGFA—age related macular degeneration	0.00192	0.00192	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CFB—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—C9—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CFH—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CFH—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—SLC16A8—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CFB—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CFB—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—C9—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—C9—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Cinchocaine—CALM3—Platelet degranulation—VEGFA—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Cinchocaine—CALM3—Disease—RPE65—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—KDR—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Cinchocaine—CALM1—Platelet degranulation—VEGFA—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Cinchocaine—CALM2—Platelet degranulation—VEGFA—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Cinchocaine—CALM3—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Cinchocaine—CALM2—Disease—RPE65—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Cinchocaine—CALM1—Disease—RPE65—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—NMNAT1—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Cinchocaine—CALM2—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Cinchocaine—CALM1—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CFI—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—NMNAT1—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—NMNAT1—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CFI—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CFI—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CFHR3—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CFHR3—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CFHR3—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ELOVL4—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—RHO—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Cinchocaine—CALM3—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ELOVL4—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ELOVL4—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Cinchocaine—CALM3—Disease—ABCA4—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—RHO—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—RHO—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RDH8—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Cinchocaine—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Cinchocaine—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—VEGFA—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Cinchocaine—CALM1—Disease—ABCA4—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Cinchocaine—CALM2—Disease—ABCA4—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—C2—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RDH8—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RDH8—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—VEGFA—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by VEGF—VEGFA—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—C2—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—C2—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by VEGF—VEGFA—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by VEGF—VEGFA—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Cinchocaine—CALM3—Disease—RHO—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RPE65—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Cinchocaine—CALM2—Disease—RHO—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Cinchocaine—CALM1—Disease—RHO—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RPE65—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RPE65—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—SLC16A8—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—SLC16A8—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—SLC16A8—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CFH—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CFB—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CFH—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CFH—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CFB—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CFB—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—ABCA4—age related macular degeneration	0.000989	0.000989	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—VEGFA—age related macular degeneration	0.000964	0.000964	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—ABCA4—age related macular degeneration	0.000956	0.000956	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—ABCA4—age related macular degeneration	0.000956	0.000956	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—LIPC—age related macular degeneration	0.00094	0.00094	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—CETP—age related macular degeneration	0.000907	0.000907	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—CD36—age related macular degeneration	0.000866	0.000866	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RHO—age related macular degeneration	0.00086	0.00086	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—CD36—age related macular degeneration	0.000837	0.000837	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—CD36—age related macular degeneration	0.000837	0.000837	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RHO—age related macular degeneration	0.000832	0.000832	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RHO—age related macular degeneration	0.000832	0.000832	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.0008	0.0008	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—CCL2—age related macular degeneration	0.000784	0.000784	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CD36—age related macular degeneration	0.000779	0.000779	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000774	0.000774	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000774	0.000774	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CST3—age related macular degeneration	0.000768	0.000768	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CD36—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CD36—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD36—age related macular degeneration	0.000748	0.000748	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CST3—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CST3—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—C3—age related macular degeneration	0.000738	0.000738	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD36—age related macular degeneration	0.000724	0.000724	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD36—age related macular degeneration	0.000724	0.000724	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—C3—age related macular degeneration	0.000714	0.000714	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—C3—age related macular degeneration	0.000714	0.000714	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—C3—age related macular degeneration	0.000709	0.000709	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CRP—age related macular degeneration	0.000703	0.000703	CbGpPWpGaD
Cinchocaine—CALM3—Disease—TGFBR1—age related macular degeneration	0.00069	0.00069	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—C3—age related macular degeneration	0.000686	0.000686	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—C3—age related macular degeneration	0.000686	0.000686	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CRP—age related macular degeneration	0.00068	0.00068	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CRP—age related macular degeneration	0.00068	0.00068	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—SQSTM1—age related macular degeneration	0.000677	0.000677	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—TLR4—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Cinchocaine—CALM1—Disease—TGFBR1—age related macular degeneration	0.000667	0.000667	CbGpPWpGaD
Cinchocaine—CALM2—Disease—TGFBR1—age related macular degeneration	0.000667	0.000667	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—SQSTM1—age related macular degeneration	0.000655	0.000655	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—SQSTM1—age related macular degeneration	0.000655	0.000655	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—TLR4—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—TLR4—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—LIPC—age related macular degeneration	0.000605	0.000605	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—LIPC—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—LIPC—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CETP—age related macular degeneration	0.000584	0.000584	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CETP—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CETP—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—CD36—age related macular degeneration	0.000545	0.000545	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000483	0.000483	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—APOE—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—C3—age related macular degeneration	0.000471	0.000471	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000467	0.000467	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000467	0.000467	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—C3—age related macular degeneration	0.000455	0.000455	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—C3—age related macular degeneration	0.000455	0.000455	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD36—age related macular degeneration	0.000454	0.000454	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD36—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD36—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000438	0.000438	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—C3—age related macular degeneration	0.00043	0.00043	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—C3—age related macular degeneration	0.000416	0.000416	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—C3—age related macular degeneration	0.000416	0.000416	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—VEGFA—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CRP—age related macular degeneration	0.000409	0.000409	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—VEGFA—age related macular degeneration	0.000399	0.000399	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—VEGFA—age related macular degeneration	0.000399	0.000399	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CRP—age related macular degeneration	0.000396	0.000396	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CRP—age related macular degeneration	0.000396	0.000396	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—TLR4—age related macular degeneration	0.000392	0.000392	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—TLR4—age related macular degeneration	0.000379	0.000379	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—TLR4—age related macular degeneration	0.000379	0.000379	CbGpPWpGaD
Cinchocaine—CALM3—Disease—APOE—age related macular degeneration	0.00037	0.00037	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCL2—age related macular degeneration	0.000368	0.000368	CbGpPWpGaD
Cinchocaine—CALM1—Disease—APOE—age related macular degeneration	0.000358	0.000358	CbGpPWpGaD
Cinchocaine—CALM2—Disease—APOE—age related macular degeneration	0.000358	0.000358	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCL2—age related macular degeneration	0.000356	0.000356	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCL2—age related macular degeneration	0.000356	0.000356	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CD36—age related macular degeneration	0.000351	0.000351	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CD36—age related macular degeneration	0.00034	0.00034	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CD36—age related macular degeneration	0.00034	0.00034	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—APOE—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—APOE—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—APOE—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—C3—age related macular degeneration	0.000278	0.000278	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—C3—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—C3—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—APOE—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—KDR—age related macular degeneration	0.000254	0.000254	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—APOE—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—APOE—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—KDR—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—KDR—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL2—age related macular degeneration	0.000218	0.000218	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL2—age related macular degeneration	0.000211	0.000211	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL2—age related macular degeneration	0.000211	0.000211	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—VEGFA—age related macular degeneration	0.00014	0.00014	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—VEGFA—age related macular degeneration	0.000135	0.000135	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—VEGFA—age related macular degeneration	0.000135	0.000135	CbGpPWpGaD
